← Open Payments lookup

EILEEN TEYIM: Open Payments

NPI 1770767014 · PLYMOUTH MEETING, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,902 in 143 payments from 17 companies in 2025. Trend: 2023 $2,120 · 2024 $2,257 · 2025 $2,902

Food & beverage: $2,759Education: $143
CompanyPaymentsAmount
ABBVIE INC.25$510
Vanda Pharmaceuticals Inc.22$490
Otsuka America Pharmaceutical, Inc.18$369
Teva Pharmaceuticals USA, Inc.11$238
Collegium Pharmaceutical, Inc.11$214
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)8$197
Takeda Pharmaceuticals U.S.A., Inc.14$189
Lundbeck LLC9$163
E.R. Squibb & Sons, L.L.C.8$150
Tris Pharma Inc4$94

Products named: VRAYLAR, FANAPT, REXULTI, Jornay PM, CAPLYTA, TRINTELLIX, COBENFY, UZEDY.

Industry payments across PA — which companies pay providers there.